Aid in the diagnosis of lymphocytic choriomeningitis (LCM) viral infection in CNS.
Semi-Quantitative Indirect Fluorescent Antibody
Transfer 1 mL CSF to an ARUP Standard Transport Tube. (Min 0.2 mL)
Contaminated, hemolyzed, or heat-inactivated specimens.
Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
|2001629||Lymphocytic Choriomeningitis (LCM) Virus Antibody, IgG, CSF||< 1:1 Negative - No significant level of LCM virus IgG antibody detected.
≥ 1:1 Positive - Presence of IgG antibody to LCM virus detected, suggestive of current or past infection.
|2001630||Lymphocytic Choriomeningitis (LCM) Virus Antibody, IgM, CSF||< 1:1 Negative - No significant level of LCM virus IgM antibody detected.
≥ 1:1 Positive - Presence of IgM antibody to LCM virus detected, suggestive of current or past infection.
The best evidence for current infection is a significant change on two appropriately timed specimens, where both tests are done in the same laboratory at the same time.
Compliance Statement D: For laboratory tests using a manufactured RUO kit. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
|Component Test Code*||Component Chart Name||LOINC|
|2001631||LCM Virus Ab, IgG, CSF||9766-7|
|2001632||LCM Virus Ab, IgM, CSF||9768-3|
- LCM Antibodies, CSF